Home
Allergies

SAE Media Group are very pleased to present its inaugural event on Allergies

Allergies represent one of the fastest growing chronic diseases. There is still no cure. There is increasing focus on the ways to treat allergies and less on the symptoms of allergic diseases. Companies are taking different approaches to control allergies in a more effective way.

The market for allergies is set to reach $14.7 billion by 2015. As companies look to develop different compounds and antibodies to treat allergies, our 2014 event marks the path forward in terms of allergies within personalised medicines and beyond.

The conference will examine novel approaches in the treatment of allergy, advances in the understanding of allergic pathophysiology: therapeutic implications, food allergies - what is new? The future of allergen-specific immunotherapy and challenges in allergy prevention, diagnosis and drug development will be explored.
 

FEATURED SPEAKERS

Alf Lindberg

Alf Lindberg

Chief Scientific Officer, Swecure
Daphne Tsitoura

Daphne Tsitoura

Senior Medical Director, Clinical Drug Development / Discovery Medicine, GlaxoSmithKline
Professor Rudolf Valenta

Professor Rudolf Valenta

, Department of Pathophysiology and Allergy Research

Alf Lindberg

Chief Scientific Officer, Swecure
Alf Lindberg

Babs Fabriek

Senior Scientist, TNO
Babs Fabriek

Birgit Linhart

Department of Pathophysiology and Allergy Research, University Of Vienna
Birgit Linhart

Chiara Nembrini

Research Scientist in Allergy, Nestle Research Center
Chiara Nembrini

Daphne Tsitoura

Senior Medical Director, Clinical Drug Development / Discovery Medicine, GlaxoSmithKline
Daphne Tsitoura

Glenis Scadding

Hon. Consultant Allergist and Rhinologist, Royal National Throat, Nose and Ear Hospital, London
Glenis Scadding

Guy Scadding

Clinical Research Fellow, National Heart and Lung Institute
Guy  Scadding

Ian Strickland

Research Scientist, MedImmune
Ian Strickland

Juan Gispert

Senior Medical Director and Chair Centre of Excellence, Quintiles
Juan Gispert

Kayhan Nouri-Aria

Lecturer, Allergy and Clinical Immunology, Imperial College London
Kayhan Nouri-Aria

Myriam Cherif

Medical Scientific Liaison – Critical Care, Novartis
Myriam  Cherif

Pam Ewan

Consultant Allergist, Addenbrookes Hospital
Pam Ewan

Philip Ashton-Rickardt

Chair in Immunology, Imperial College Administration
Philip Ashton-Rickardt

Professor Rudolf Valenta

, Department of Pathophysiology and Allergy Research
Professor Rudolf Valenta

Rainer Henning

CEO, Biomay AG
Rainer  Henning

Suranjith Seneviratne

Consultant in Clinical Immunology and Allergy, Royal Free Hospital
Suranjith Seneviratne

Conference agenda

clock

13:00

Registration and coffee

clock

13:30

Welcome and introduction to Quintiles

clock

13:45

Proof of concept studies

  • Biomarkers in allergic diseases
  • Challenge tests
  • Tips to increase probability of success for go/no go decisions
  • clock

    14:45

    Coffee break

    clock

    15:00

    Dose finding and efficacy trials

  • Study design
  • Efficacy and safety outcomes
  • Study strategy; selecting the most appropriate countries and sites
  • clock

    16:00

    Coffee break

    clock

    16:15

    Late Phase Real World Studies in IT

  • Working with Real World Sites
  • Managing Real World Data
  • Case Study
  • clock

    17:15

    Conclusions and close of workshop

    clock

    8:30

    Registration and coffee

    clock

    9:00

    Chairman's opening remarks

    Daphne Tsitoura

    Daphne Tsitoura, Senior Medical Director, Clinical Drug Development / Discovery Medicine, GlaxoSmithKline

    Philip Ashton-Rickardt

    Philip Ashton-Rickardt, Chair in Immunology, Imperial College Administration

    clock

    9:10

    Toll-like receptor agonists: a new therapeutic tool for allergies

    Daphne Tsitoura

    Daphne Tsitoura, Senior Medical Director, Clinical Drug Development / Discovery Medicine, GlaxoSmithKline

  • Rationale for the use of TLR agonists in the treatment of immunological disorders
  • Clinical investigations in allergy
  • Challenges and next steps
  • clock

    9:50

    Preclinical advances in Atopic Dermatitis

    Ian Strickland

    Ian Strickland, Research Scientist, MedImmune

  • Mechanisms relevant to atopic dermatitis
  • New animal models of disease
  • Clinical progress in MedImmune asthma portfolio and potential value of current asthma assets for atopic dermatitis
  • clock

    10:30

    Morning coffee

    clock

    11:00

    Targeting inflammation in allergic asthma

    Myriam  Cherif

    Myriam Cherif, Medical Scientific Liaison – Critical Care, Novartis

     

  • ·          Targeting inflammation in allergic asthma: new and old biomarkers
  • ·          Towards personalised medicine in asthma: myth or reality?
  • ·          The changing landscape in the treatment of asthma
  • clock

    11:40

    Current status of food allergy management

    Chiara Nembrini

    Chiara Nembrini, Research Scientist in Allergy, Nestle Research Center

  • Our approaches to managing allergies globally
  • Exploring the challenges in food immunotherapy
  • Developing advances in food allergy treatment
     
  • clock

    12:20

    Networking lunch

    clock

    13:40

    The puzzle of non-allergic eosinophilic inflammation in the respiratory tract

    Glenis Scadding

    Glenis Scadding, Hon. Consultant Allergist and Rhinologist, Royal National Throat, Nose and Ear Hospital, London

     

  • ·          Evaluating non-allergic rhinitis comprising different conditions, not all inflammatory
  • ·          Analysing the incomplete understanding of allergic rhinitis
  • ·          The role of eosinophilic inflammation in non-allergic disease
  • ·          Discussion of the aetiopathology of non-allergic eosinophilia in the upper airway and non-allergic lower airways disease
     
  • clock

    14:20

    Targeting memory Th2 cells in allergic diseases. From Model to Man

    Philip Ashton-Rickardt

    Philip Ashton-Rickardt, Chair in Immunology, Imperial College Administration

     

    ·          Emerging role of memory Th2 cells in allergy
    ·          Targeting memory Th2 cells
    ·          Case study on a new target for the elimination of memory Th2 cells
    clock

    15:00

    Afternoon tea

    clock

    15:30

    Allergen-specific immunotherapy: current and novel approaches

    Guy  Scadding

    Guy Scadding, Clinical Research Fellow, National Heart and Lung Institute

     

  • ·          Who should we select for allergen-specific immunotherapy?
  • ·          Current treatment options and their limitations
  • ·          Novel approaches to improve safety and efficacy
  • clock

    16:10

    Mechanisms of SLIT: the role of dendritic cells

    Kayhan Nouri-Aria

    Kayhan Nouri-Aria, Lecturer, Allergy and Clinical Immunology, Imperial College London

  • ·          SLIT – a safe, injection free and alternative to SCIT
  • ·          Focus on the sublingual region – transporting the allergen to the local lymph node by DCs
  • ·          How to facilitate tolerogenic immune responses during SLIT
  • clock

    16:40

    Chairman's closing remarks

    clock

    8:30

    Registration and coffee

    clock

    9:00

    Chairman's opening remarks

    Daphne Tsitoura

    Daphne Tsitoura, Senior Medical Director, Clinical Drug Development / Discovery Medicine, GlaxoSmithKline

    Philip Ashton-Rickardt

    Philip Ashton-Rickardt, Chair in Immunology, Imperial College Administration

    clock

    9:10

    Advances with recombinant allergy vaccines: the future of allergy immunotherapy

    Rainer  Henning

    Rainer Henning, CEO, Biomay AG

  • ·          Identify the shortcomings of specific allergy immunotherapy as practiced today
  • ·          Discussion of the principles of recombinant or synthetic allergy vaccines
  • ·          Discussion of preclinical efficacy, available clinical results and future clinical impact of these vaccines
  • clock

    9:50

    Passive immunisation with allergen-specific IgG antibodies for the treatment and prevention of allergy

    Birgit Linhart

    Birgit Linhart, Department of Pathophysiology and Allergy Research, University Of Vienna

     

  • ·          Role of allergen-specific IgG antibodies for treatment and prevention of allergy and understanding the mechanisms of action
  • ·          Available allergen-specific antibodies and technologies for generation allergen-specific IgG antibodies for treatment and prevention
  • ·          Strategies for therapy and prevention of allergy based on allergen-specific IgG
     
  • clock

    10:30

    Morning coffee

    clock

    11:00

    Peanut allergy treatment - a success

    Pam Ewan

    Pam Ewan, Consultant Allergist, Addenbrookes Hospital

  • The impact of peanut allergy
  • Discussion of findings during the immunotherapy trials 
  • clock

    11:40

    Prevention of food allergies: how to deal with the proteins of the future

    Babs Fabriek

    Babs Fabriek, Senior Scientist, TNO

  • ·          How to assess the risk of novel proteins
  • ·          How we can rank the allergenic proteins in potency
  • ·          Exploring the prevalence of known allergies in the population
  • clock

    12:20

    Networking lunch

    clock

    13:30

    Case study: Allergy prevention in an era of personalised medicine

    Alf Lindberg

    Alf Lindberg, Chief Scientific Officer, Swecure

     

  • ·          Gaining an insight into allergy prevention techniques and methodologies
  • ·          Developing our work from the pre-clinical through to the clinical stages
  • ·          Conclusions discussed and the path forward
  • clock

    14:10

    Advances in allergy diagnostics: moving from the bench to the clinic

    Suranjith Seneviratne

    Suranjith Seneviratne, Consultant in Clinical Immunology and Allergy, Royal Free Hospital

     

  • ·          Discussion of recent findings in allergy diagnostics
  • ·          How do they impact on patient management
  • ·          Potential future developments in the field
  • clock

    14:50

    Insights for the clinical development of drugs for allergic diseases

    Juan Gispert

    Juan Gispert, Senior Medical Director and Chair Centre of Excellence, Quintiles

  • ·          How to improve study designs, pharmacological and regulatory perspective
  • ·          Tips and pitfalls in the recruitment of Allergic patients
  • ·          Ethical concerns in allergy trials
     

     

     
  • clock

    15:30

    Chairman's closing remarks

    clock

    15:40

    Afternoon tea


    Senior Medical Director, Clinical Drug Development / Discovery Medicine
    GlaxoSmithKline
    Consultant Allergist
    Addenbrookes Hospital
    Clinical Research Fellow
    National Heart and Lung Institute
    Senior Medical Director and Chair Centre of Excellence
    Quintiles
    Chief Scientific Officer
    Swecure
    CEO
    Biomay AG
    Department of Pathophysiology and Allergy Research
    University Of Vienna
    Medical Scientific Liaison – Critical Care
    Novartis
    Hon. Consultant Allergist and Rhinologist
    Royal National Throat, Nose and Ear Hospital, London
    Consultant in Clinical Immunology and Allergy
    Royal Free Hospital
    Senior Scientist
    TNO
    Chair in Immunology
    Imperial College Administration
    Research Scientist in Allergy
    Nestle Research Center
    Lecturer, Allergy and Clinical Immunology
    Imperial College London
    Research Scientist
    MedImmune
    Department of Pathophysiology and Allergy Research

    Workshops

    Interview with Nestle

    Download

    Interview with Dr. Kayhan Nouri-Aria

    Download

    Holiday Inn Regents Park

    Carburton Street
    London W1W 5EE
    United Kingdom

    Holiday Inn Regents Park

    Choose the well-connected Holiday Inn London-Regent's Park hotel, with a superb central London location and speedy transport links. Holiday Inn London-Regent's Park is in a leafy and cosmopolitan area of central London, a 10-minute walk from bustling Oxford Street. Leave your car in our NCP managed underground car park, and explore London by Tube. Great Portland Street Tube station is 25 metres from the hotel, from where you can reach the City and Canary Wharf in 30 minutes, and London Heathrow Airport in 45 minutes.

    Wireless Internet is available throughout the hotel, and you can invite up to 300 people to events at the Academy Conference Centre, with an IT technician and break-out zones. Holiday Inn London-Regent's Park is a 10-minute walk from Santander's offices and businesses in the BT Tower. Stroll 5 minutes to Regent's Park, where you'll find London Zoo and pretty Primrose Hill. We're a 10-minute walk from Bond Street boutiques and 20 minutes from Buckingham Palace and cruises on the River Thames.

    Ask our Concierge to plan your day out and book West End theatre tickets. Room Service is available 24 hours at Holiday Inn London-Regent's Park, or dine in the vibrant Junction Restaurant. Our Junction Bar has a menu of light bites, and a hot breakfast buffet is served daily.

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.